Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing
Key Points
Alpha Wave Global LP sold 63,147 shares of RadNet (RDNT)
Quarter-end position value decreased by $11.90 million, reflecting both trading and price movement
Transaction represented approximately 0.55% of Alpha Wave Global’s 13F reportable AUM
Post-trade holding: 478,304 shares valued at $26.73 million
RadNet now accounts for 3.38% of fund AUM, which places it outside the fund's top five holdings
- 10 stocks we like better than RadNet ›
What happened
According to an SEC filing dated May 14, 2026, Alpha Wave Global, LP reduced its RadNet (NASDAQ:RDNT) position by 63,147 shares in the first quarter. The estimated value of this trade is approximately $4.31 million based on the period’s average closing price. The fund’s quarter-end stake was 478,304 shares, with a reported value of $26.73 million.
What else to know
Alpha Wave Global, LP reduced its exposure to RadNet and the position now represents 3.38% of its 13F AUM.
Top holding after the filing:
- NASDAQ:LENZ: $33.05 million (4.2% of AUM)
As of May 13, 2026, RadNet shares were priced at $52.98, down 12.5% over the past year, underperforming the S&P 500 by 38.9 percentage points.
Company Overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $2.14 billion |
| Net Income (TTM) | $-14.19 million |
| Price (as of market close 2026-05-13) | $52.98 |
| One-Year Price Change | -12.47% |
Company Snapshot
RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, operating a large network of imaging centers and leveraging advanced technology to enhance radiology workflows. The company combines traditional imaging services with proprietary IT and artificial intelligence solutions, supporting both clinical efficiency and diagnostic accuracy. RadNet's scale, diversified service offerings, and ongoing investment in AI-driven innovation position it as a key player in the evolving medical diagnostics sector.
RadNet Inc. provides outpatient diagnostic imaging services, including MRI, CT, PET, nuclear medicine, mammography, ultrasound, and related procedures, as well as AI-driven software solutions for radiology. It operates a network of imaging centers and generates revenue primarily through patient imaging services and the development and sale of diagnostic imaging IT systems and AI products.
RadNet Inc. serves referring physicians, healthcare systems, and patients across multiple U.S. states, focusing on outpatient care and enterprise imaging solutions.
What this transaction means for investors
RadNet combines one of the country’s largest outpatient imaging networks with DeepHealth, its AI-enabled radiology workflow and screening platform. The imaging-center business remains the foundation, driven by patient volume, demand for advanced imaging, health-system partnerships, and center-level efficiency. DeepHealth adds a higher-growth digital layer, but it still has to prove that rapid revenue growth can turn into scalable profit.
RadNet’s first quarter results reinforce the investment case for its imaging network. Revenue increased 22.1% to $575.6 million, and adjusted EBITDA rose 36.3% to $63.3 million, driven by higher advanced imaging volumes across MRI, CT, and PET/CT. Digital Health’s ARR grew to $96.9 million, though segment profitability declined due to infrastructure investments supporting a larger sales pipeline.
In the near term, investors should focus on RadNet’s execution in imaging. Sustained growth depends on advanced imaging volume, center productivity, and health-system partnerships. The longer-term opportunity is where DeepHealth becoming a larger recurring-revenue contributor without requiring disproportionate investment from the core imaging business.
Should you buy stock in RadNet right now?
Before you buy stock in RadNet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and RadNet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $462,983!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,375,447!*
Now, it’s worth noting Stock Advisor’s total average return is 995% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of June 2, 2026.
Eric Trie has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Boeing and QXO. The Motley Fool has a disclosure policy.
Recommended Articles
